Eli Lilly & Co. Global External R&D-Asia VP Tony Zhang On Lilly's FIPNET Strategies In China
This article was originally published in The Pink Sheet Daily
Executive Summary
Zhang discusses Lilly's strategies in an interview with PharmAsia News' Shanghai bureau editors.